Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Urinary Bladder Neoplasms × temsirolimus × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 7 Sarcoma 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Melanoma 4 Carcinoma, Hepatocellular 4 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Congenital Abnormalities 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 72 Cisplatin 51 pembrolizumab 24 Paclitaxel 20 Cystectomy 19 Carboplatin 18 Nivolumab 16 durvalumab 15 atezolizumab 14 Docetaxel 14 Specimen Handling 13 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 avelumab 11 Fluorouracil 11 Sunitinib 10 Mitomycin 10 Doxorubicin 10 Methotrexate 9 Vinblastine 8 Filgrastim 7 Ipilimumab 6 BCG Vaccine 6 Standard of Care 5 Radiation 5 Platinum 5 Immunoglobulin G 5 Erlotinib Hydrochloride 5 Disulfides 5 Cystoscopy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01827943 2021-05-06

VESTOR

Institut Bergonié

Phase 2 Completed

54 enrolled 8 charts

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡